Results 51 to 60 of about 1,518,675 (340)
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is ...
Julio S Solís Arce +73 more
semanticscholar +1 more source
COVID-19: Vaccines and therapeutics
Coronavirus disease 2019 (COVID-19) is a communicable disease triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as leading cause of death from a single infectious agent globally. Despite of rigorous protective measures, availability of multiple vaccines and with few approved therapeutics, the virus effect on the ...
Ponnampalli, Swapna +2 more
openaire +2 more sources
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), an emerging virus in late 2019 causing coronavirus disease 2019 (COVID‐19), has caused a catastrophic effect, resulting in an unprecedented global crisis.
Yibeltal Akelew +4 more
doaj +1 more source
BackgroundThere are concerns that vaccine hesitancy may impede COVID-19 vaccine rollout and prevent the achievement of herd immunity. Vaccine hesitancy is a delay in acceptance or refusal of vaccines despite their availability.
Jamie L Benham +16 more
doaj +1 more source
Where 2020 saw the development and testing of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has seen vaccine rollout in many countries.
J. Tregoning +4 more
semanticscholar +1 more source
COVID-19 Vaccination and Glomerulonephritis [PDF]
mRNA COVID-19 vaccine is more effective than traditional vaccines owing to superior immune activation. Nevertheless, the impact of mRNA COVID-19 vaccine on triggering de novo/relapsing glomerulonephritis (GN) is limited. We report a case series of patients who developed new or relapsing GN postvaccination.We evaluated baseline characteristics, vaccine ...
Nattawat Klomjit +8 more
openaire +2 more sources
ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine efficacy against the B.1.351 variant
Background Assessing safety and efficacy of Covid-19 vaccines in different populations is essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern including the B.1.351 (501Y.V2) variant first identified in South Africa.
S. Madhi +50 more
semanticscholar +1 more source
Vaccine hesitancy is a top ten global health threat that can negatively impact COVID-19 vaccine uptake. It is assumed that vaccine refusers hold deep, negative beliefs, while acceptors hold strong, positive beliefs.
Kimberly K. Walker +3 more
doaj +1 more source
The COVID-19 pandemic has left an indelible mark on global health, affecting individuals of all ages across diverse communities. While the virus has predominantly been associated with severe outcomes in adults, its impact on children has garnered increasing attention. Today, three COVID-19 vaccines are available for use in the U.S.
Fayad, Danielle, Frenck, Robert W.
openaire +2 more sources
Importance Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance.
Emma K. Accorsi +8 more
semanticscholar +1 more source

